Optimizing the Effect of COPD Rehabilitation

  • Tell a FriendPrint

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up...

Brief Summary

Official Title: “Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation”

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Detailed Clinical Trial Description

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine. However, the effect of programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Intervention(s) in this Clinical Trial

  • Behavioral: follow-up rehabilitation of participants with COPD

Outcome Measures for this Clinical Trial

Primary Measures

  • Disease specific Quality of Life
  • Work Capacity

Secondary Measures

  • Number of days admitted to hospital

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • FEV1 < 60% of expected

Exclusion Criteria:

  • Other severe chronic conditions

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Glostrup University Hospital, Copenhagen Other

Overall Clinical Trial Officials and Contacts

Susanne Vest, MD Principal Investigator Glostrup University Hospital, Copenhagen  

Overall Contact: Susanne Vest, MD  susanne.vest@dadlnet.dk

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00419289

Study ID Number: KA20060179

ClinicalTrials.gov Identifier: NCT00419289

Health Authority: Denmark: Ethics Committee

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00419289